Browsing "1. Journal Papers" by Author : 5541

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 18 of 18

This table browses all dspace content
Issue DateTitleJournal Title
2022A Comparison of 2 Disease Burden Assessment Methods (3D Volume Versus the Number of Lesions) for Prognostication of Survival in Metastatic Melanoma: Implications for the Characterization of Oligometastatic DiseaseINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2022A Multicenter Two-arm, Phase II Trial Assessing the Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer (ABLATE, KCSG-LU21-11)CLINICAL LUNG CANCER
2021Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple MyelomaCLINICAL CANCER RESEARCH
2024Aggressive Local Ablative Radiotherapy Mitigates Progression Risk in Oligometastatic Lung Adenocarcinoma CANCER RESEARCH AND TREATMENT
2022Association of Sinoatrial Node Radiation Dose With Atrial Fibrillation and Mortality in Patients With Lung CancerJAMA ONCOLOGY
2022Automated coronary artery calcium scoring in patients with breast cancer to assess the risk of heart disease following adjuvant radiation therapy BREAST
2023Clinical Outcomes of Thymic Carcinoma: The Role of Radiotherapy Combined with Multimodal Treatments CANCERS
2021Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer JOURNAL FOR IMMUNOTHERAPY OF CANCER
2021Dynamic changes in circulating PD-1(+)CD8(+)T lymphocytes for predicting treatment response to PD-1 blockade in patients with non-small-cell lung cancerEUROPEAN JOURNAL OF CANCER
2022First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600-mutant advanced melanomaJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
2020Gene Expression Profiling Identifies Akt as a Target for Radiosensitization in Gastric Cancer Cells FRONTIERS IN ONCOLOGY
2021Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinomaJOURNAL OF HEPATOLOGY
2022Increased Radiosensitivity of Solid Tumors Harboring ATM and BRCA1/2 Mutations CANCER RESEARCH AND TREATMENT
2021PD-1 blockade-unresponsive human tumor-infiltrating CD8 + T cells are marked by loss of CD28 expression and rescued by IL-15CELLULAR & MOLECULAR IMMUNOLOGY
2022Predicting treatment outcomes using 18 F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapy THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2021Prediction of Immune-Checkpoint Blockade Monotherapy Response in Patients With Melanoma Based on Easily Accessible Clinical Indicators FRONTIERS IN ONCOLOGY
2021Risk of Cardiac Disease in Patients With Breast Cancer: Impact of Patient-Specific Factors and Individual Heart Dose From Three-Dimensional Radiation Therapy PlanningINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2022Treatment outcomes and radiotherapy deintensification strategies in human papillomavirus-associated tonsil cancer RADIATION ONCOLOGY
1

Browse

Links